Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Anaptysbio (ANAB) Equity Ratio (2016 - 2025)

Anaptysbio filings provide 10 years of Equity Ratio readings, the most recent being 0.1 for Q4 2025.

  • For the quarter ending Q4 2025, Equity Ratio fell 30.28% year-over-year to 0.1, compared with a TTM value of 0.1 through Dec 2025, down 30.28%, and an annual FY2025 reading of 0.1, down 30.28% over the prior year.
  • Equity Ratio hit 0.1 in Q4 2025 for Anaptysbio, up from 0.08 in the prior quarter.
  • The five-year high for Equity Ratio was 0.96 in Q1 2021, with the low at 0.13 in Q2 2025.
  • Median Equity Ratio over the past 5 years was 0.27 (2023), compared with a mean of 0.34.
  • The sharpest move saw Equity Ratio rose 2.04% in 2021, then plummeted 677.24% in 2025.
  • Year by year, Equity Ratio stood at 0.55 in 2021, then decreased by 22.53% to 0.43 in 2022, then plummeted by 54.65% to 0.19 in 2023, then fell by 24.79% to 0.15 in 2024, then tumbled by 30.28% to 0.1 in 2025.
  • According to Business Quant data, Equity Ratio over the past three periods came in at 0.1, 0.08, and 0.13 for Q4 2025, Q3 2025, and Q2 2025 respectively.